Gabapentin is not classified as an ototoxic drug. Unlike medications such as certain antibiotics and chemotherapy agents that directly damage the structures of the inner ear, gabapentin does not appear to harm the cochlea or auditory nerve. However, it can occasionally cause ear-related side effects, including tinnitus and, in rare circumstances, hearing changes, likely through its effects on the brain rather than the ear itself.
What the FDA Label Says About Ear Side Effects
The FDA-approved labeling for gabapentin (Neurontin) lists tinnitus as an “infrequent” side effect, meaning it occurred in somewhere between 1 in 100 and 1 in 1,000 patients across clinical trials. In controlled trials for postherpetic neuralgia specifically, no separate hearing loss category appeared among common adverse events. The ear-related finding that did show up was middle ear infection at 1.2% of gabapentin-treated patients versus 0% on placebo, which is unrelated to ototoxicity.
These numbers place gabapentin’s risk to hearing far below that of truly ototoxic drugs, where hearing damage can affect a significant percentage of patients and may be permanent. With gabapentin, ear symptoms are uncommon and appear to involve how the brain processes sound rather than physical damage to the ear.
How Gabapentin Affects Auditory Processing
Gabapentin works by boosting the activity of GABA, an inhibitory brain chemical that helps quiet excessive nerve signaling. This is relevant to hearing because the brain’s auditory centers rely on a careful balance between excitatory and inhibitory signals. When GABA activity shifts, it can change how you perceive sound, potentially creating the sensation of ringing or fullness without any structural damage to the ear.
Animal research supports this connection. Studies in rats have shown that lowering GABA levels in the part of the brainstem that processes sound can produce both tinnitus and hearing loss. Gabapentin does the opposite, raising GABA activity, which is why it has actually been studied as a treatment for tinnitus rather than a cause of it. The occasional reports of tinnitus in people taking gabapentin likely reflect individual differences in how the drug shifts this balance.
The Rare Case of Hearing Loss
One published case report describes a patient with kidney failure who developed hearing loss along with confusion, hallucinations, and involuntary muscle jerking while taking gabapentin. On admission, the patient’s gabapentin blood level was 17.6 micrograms per milliliter, far above the typical therapeutic range. The kidneys are responsible for clearing gabapentin from the body, so when they aren’t working properly, the drug accumulates.
The hearing loss in this case lasted about three days and resolved once the drug was cleared from the patient’s system through dialysis. By day four, gabapentin was undetectable in the blood and symptoms had resolved. This pattern, where symptoms appear at toxic concentrations and disappear once levels drop, points to a brain-mediated effect rather than permanent inner ear damage. True ototoxic injury, by contrast, often persists after the drug is stopped because the sensory cells in the ear don’t regenerate.
Gabapentin as a Tinnitus Treatment
Interestingly, gabapentin has been tested as a remedy for the very symptom it occasionally causes. A randomized controlled trial of 103 patients with tinnitus from acoustic trauma found that gabapentin at 300 mg twice daily for six weeks reduced tinnitus severity significantly more than placebo. About 89% of patients in the gabapentin group experienced at least a 30% reduction in their tinnitus scores, compared to 58% in the control group.
This paradox, a drug that treats tinnitus in most people but triggers it in a few, makes more sense when you consider that tinnitus has many underlying mechanisms. In trauma-related tinnitus, the brain’s auditory circuits are overactive, and gabapentin’s calming effect helps. In the small number of people who develop tinnitus on gabapentin, the drug may be shifting inhibitory signaling in a way that their particular nervous system interprets as noise. The context matters: what helps one type of auditory dysfunction can occasionally worsen another.
Who Should Pay Attention
If you have normal kidney function and are taking gabapentin at standard doses, the risk of any hearing-related side effect is low. The people most vulnerable to ear symptoms are those whose kidneys don’t clear the drug efficiently, allowing blood levels to climb higher than intended. This includes people with chronic kidney disease, older adults with age-related kidney decline, and anyone experiencing acute kidney problems.
If you notice new ringing in your ears or a change in hearing after starting gabapentin or after a dose increase, that information is worth bringing to whoever prescribed the medication. Based on available evidence, these symptoms typically resolve with dose adjustment or discontinuation. They do not indicate permanent damage to the inner ear structures, which is what true ototoxicity means.